With a profound accounting background in responsible positions in the pharmaceutical industries such as Actavis and Xantis, Oliver has extensive experience with business models up to a very large scale.

Oliver´s analytical expertise is highly valued and has been of significant relevance, especially in Due Diligence and restructuring processes.

Oliver currently serves several board positions.